90 related articles for article (PubMed ID: 8685224)
1. The prognostic importance of nuclear morphometry and the MIB-1 index in rhabdomyosarcoma [corrected].
Noguchi S; Tamiya S; Nagoshi M; Suita S; Fukuda T; Tsuneyoshi M
Mod Pathol; 1996 Mar; 9(3):253-60. PubMed ID: 8685224
[TBL] [Abstract][Full Text] [Related]
2. The role of nuclear morphometry in prediction of prognosis for rhabdomyosarcoma in children.
Kazanowska B; Jelen M; Reich A; Tarnawski W; Chybicka A
Histopathology; 2004 Oct; 45(4):352-9. PubMed ID: 15469473
[TBL] [Abstract][Full Text] [Related]
3. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
Karbowniczek M; Chosia M; Domagała W
Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
[TBL] [Abstract][Full Text] [Related]
4. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis.
Coffin CM; Rulon J; Smith L; Bruggers C; White FV
Mod Pathol; 1997 Dec; 10(12):1175-87. PubMed ID: 9436961
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
6. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
8. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
[TBL] [Abstract][Full Text] [Related]
9. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.
Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R
Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody].
Juszkiewicz P
Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma.
Nishi T; Kuratsu J; Takeshima H; Saito Y; Kochi M; Ushio Y
Int J Mol Med; 1999 Feb; 3(2):157-61. PubMed ID: 9917523
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in childhood rhabdomyosarcoma.
San Miguel-Fraile P; Carrillo-Gijón R; Rodriguez-Peralto JL; Badiola IA
Am J Clin Pathol; 2004 Mar; 121(3):358-65. PubMed ID: 15023040
[TBL] [Abstract][Full Text] [Related]
16. [Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].
Matsumoto K; Tanimoto K; Michitaka K; Furutani T; Nakaya M; Horiike N; Onji M
Rinsho Byori; 1999 Oct; 47(10):956-60. PubMed ID: 10590670
[TBL] [Abstract][Full Text] [Related]
17. [Significance of differential nuclear expression of Ki-67 in adult soft tissue sarcomas].
Rohr UP; Heinzinger M; Rheinländer B; Parwaresch R; Bohle RM
Verh Dtsch Ges Pathol; 1998; 82():345-50. PubMed ID: 10095458
[TBL] [Abstract][Full Text] [Related]
18. Findings of computerised nuclear morphometry of papillary thyroid carcinoma in correlation with known prognostic factors.
Tseleni S; Kavantzas N; Yova D; Alexandratou E; Karydakis V; Gogas J; Davaris P
J Exp Clin Cancer Res; 1997 Dec; 16(4):401-6. PubMed ID: 9505213
[TBL] [Abstract][Full Text] [Related]
19. [Expression of a proliferation associated-nuclear antigen defined by Ki-67 monoclonal antibody in childhood acute leukemia].
Ito M; Tsurusawa M; Kawai S; Fujimoto T
Rinsho Ketsueki; 1995 Aug; 36(8):713-9. PubMed ID: 7563603
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
